Juniper Pharma (JNP) Tops Q1 EPS by 11c

Juniper Pharma (NASDAQ: JNP) reported Q1 EPS of $0.03, $0.11 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Investing.com’s stocks of the week
• Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
• TFS Financial (TFSL) Tops Q3 EPS by 3c